Mizuho Securities Reaffirms Their Buy Rating on Surgery Partners (SGRY)
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Hynes covers the Healthcare sector, focusing on stocks such as UnitedHealth, Acadia Healthcare, and Humana. According to TipRanks, Hynes has an average return of 8.9% and a 59.68% success rate on recommended stocks.
Currently, the analyst consensus on Surgery Partners is a Moderate Buy with an average price target of $31.22, representing a 53.57% upside. In a report released today, Leerink Partners also reiterated a Buy rating on the stock with a $34.00 price target.
The company has a one-year high of $33.97 and a one-year low of $19.50. Currently, Surgery Partners has an average volume of 998.6K.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Looking for AI Chip Stocks Beyond Nvidia? Goldman Sachs Says These 2 Names Deserve a Look
The AI boom has been generating hype and headlines for several years now, and deservedly so. It's transforming the way businesses operate, reshaping everything from data crunching and decision-making to customer service and content generation. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. AI might exist in a data cloud, but it requires hardware. The AI companies need data centers, high-performance computers, and advanced networking – and all of that requires silicon semiconductors, many of them custom-designed. Chip giant Nvidia, with its $4 trillion market cap, is the 800-pound gorilla in this room, but there are other names that investors can look to for profits. Covering the fields of tech, AI, and semiconductors, Goldman Sachs analyst James Schneider points out the contours of the field and its opportunities, writing: 'We believe the AI investment cycle is in a state of transition, with over $350bn in CapEx spent on AI infrastructure. Although monetization has been elusive, we see early signs of incremental revenue and much clearer evidence of cost takeout to justify these investments – and we believe AI CapEx can sustain growth from current levels.' Schneider follows on from these comments by tagging two chip names that deserve a closer look. It doesn't hurt that both stocks also carry Strong Buy ratings from the broader Street, according to the TipRanks database. Let's take a closer look. Cadence Design Systems (CDNS) The first stock on our radar here is Cadence Design, a high-tech firm from San Jose, California, in the heart of Silicon Valley. Cadence provides the technology and support necessary for some of our world's most important industries to thrive. The company uses its Intelligent Design System to develop its products and software, and its services are in high demand everywhere from the chip industry to the pharmaceutical sector. Cadence's solutions include 3D-IC design, 5G systems, Artificial Intelligence and generative AI, an extensive cloud portfolio, data center design, multiphysics systems analysis – it's a long list, as Cadence has connections across the tech world. Its products and tech are used in a wide range of essential secondary products, including silicon chips, integrated circuit boards – items that are used everywhere from the aerospace sector to the life sciences, and including plenty of AI applications. It's not just that Cadence's own work is applicable to AI, but also that the company uses AI, and AI-powered applications, to support its work and develop its product lines. The company uses agentic AI to help engineers meet the challenges presented by the latest chip designs, and its generative AI platform has the potential to transform semiconductor chip design. Finally, Cadence's AI IP platform provides comprehensive solutions in the worlds of IP and software. When we look ahead, we see that Cadence's contribution to chip design gives the company a strong foundation from which to grow. Hyperscale AI and cloud providers – think Amazon, Google, and Microsoft – have a definite need for custom chips that are designed to handle high volumes at lower cost, and Cadence is well-placed to fill that niche. Turning to Cadence's financial performance, we find that in 1Q25, at the bottom line, the non-GAAP EPS of $1.57 was up 40 cents per share from 1Q24 and was 7 cents higher than the forecast. Revenue, at $1.24 billion, was up 23% year-over-year and met Street expectations. Cadence finished Q1 with a work backlog of $6.4 billion. For Goldman's Schneider, the key points here are the quality of Cadence's business and the high potential of the company to continue growing. He says of this AI-adjacent tech firm, 'We see Cadence as one of the most high-quality compounding businesses in our coverage, with exposure to multiple drivers of growth throughout the industry. We see long-term growth driven by the diffusion of custom chip design across a broader range of customers with an outsized need for IP…' Based on this stance, Schneider rates CDNS as a Buy, which he complements with a $380 price target that suggests a one-year upside potential to the stock of 19.5%. (To watch Schneider's track record, click here) Cadence has a Strong Buy consensus rating from the Street's analysts, based on 15 recent reviews which break down 14 to 1 in favor of Buy over Hold. The shares are priced at $318.04 and their $338.64 average price target implies a 6.5% gain for the next 12 months. (See CDNS stock forecast) Broadcom, Inc. (AVGO) Next up is a company more directly tied to the field of AI chips. Broadcom is a giant of the chip industry; with its market cap of $1.30 trillion, it's the second-largest chip maker on the global scene – and the eighth-largest publicly traded company on Wall Street. While Broadcom's business has been built on a wide variety of products and product lines, from cable modems to fiber optics to wireless connectivity, the company's current strengths include AI-capable chips and application-specific integrated circuits, or ASICs. These are a key technology in the AI field and also underlie the functioning of cloud-based systems. ASICs are custom-made to the buyer's/user's specifications, which makes them more efficient in terms of power consumption and processing speed. In AI, cloud, and data center applications, these are vital advantages. Broadcom is known as a solid provider of silicon chips and other technology in the data center world, able to provide, at any scale, the hardware needed to build out high-performance server stacks and to develop and maintain high-speed connectivity. The company is also working on the next generation of AI-capable technologies, from connectivity solutions to custom accelerators, that will revolutionize the AI industry in ways that are still just in the outline stage. Broadcom's development work is part of a coherent strategy that will keep the company relevant as a technology supplier as the AI sector evolves. The company's current success, and its sheer scale, give it a sound foundation for continued leadership in the field. Broadcom's leading position in data center switching, and its reputation for high-quality, high-speed networking, are both attractive to the AI industry's hyperscalers, and the company can leverage its own scale to meet the needs of its largest customers. In the recently reported fiscal 2Q25, Broadcom generated $15 billion in total revenue. This figure was up 20% from fiscal 2Q24, and it beat the forecast by $30 million. The company's earnings came to $1.58 per share by non-GAAP measures, a penny better than had been estimated. Management attributed $4.4 billion of the quarterly revenue to AI, a subtotal that was up 46% year-over-year. The gain in AI revenue was supported by strong demand for AI networking. Scale and profitability are valuable assets for any company, especially one targeting an industry experiencing the powerful growth that currently characterizes AI. This caught the attention of Goldman Sachs, and when we check in again with analyst Schneider, we find him upbeat on AVGO, writing, 'We believe the company will leverage its leadership in enterprise networking silicon to drive outsized share in custom silicon for hyperscalers, with AI likely comprising over 40% of revenue by 2026. Broadcom also continues to generate steady, growing profitability in its infrastructure software business. We see the stock's premium valuation as justified by the visibility provided by sole-sourcing at silicon accounts and the mission-critical nature of its software portfolio.' Schneider puts a Buy rating on AVGO, and his price target of $315 implies that the stock will gain 12% by this time next year. Broadcom has picked up 30 recent analyst reviews, and these have a lopsided split of 28 Buys to 2 Holds to support the Strong Buy consensus rating. Shares in AVGO are currently trading for $280.94, and their $300.96 average price target points toward a one-year gain of 7%. (See AVGO stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment. Disclaimer & DisclosureReport an Issue Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
7 hours ago
- Business Insider
Intel Stock (NASDAQ:INTC) Continues Slide as it Abandons AI Training
Honestly, right now, it is hard to tell whether to give chip stock Intel (INTC) credit for a newfound focus or be terrified that it is on its way to producing virtually nothing. In fact, Intel recently called it quits in the artificial intelligence (AI) training market, a move which left shareholders shaken. Intel shares dropped nearly 2% in Wednesday afternoon's trading. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. In something of a bold move, Intel departed one market to focus instead on another: inference. Specifically, Intel is now set to focus on '…edge and agent-based' inference, a move which might actually be better for Intel in the long run. Reports suggest that the inference market may ultimately surpass the training market in terms of overall value. After the Gaudi 3 chip failed to make much impact on the market, Intel instead pulled back to edge AI, agentic AI, and foundry services. Edge AI refers to both 'local' systems that do not need data center or cloud data deployments and some remote systems not connected to larger operations. Agentic AI, meanwhile, focuses on chips that can act without much, if any, human intervention. 18A Process Remains Uncertain There were some signs, first seen not so long ago, that suggested Intel may be planning to shut down the 18A process. And new reports lend at least some credence to that theory, though not a complete admission of abandonment. The new reports suggest that Intel is likely to use the 18A process to fabricate the Panther Lake line of mobile processors. But the Nova Lake processors are instead being taped-out through the N2 process from Taiwan Semiconductor (TSM). Intel was already an 'early client' for the N2 process, and it seems like it may be putting that process to work before it can get the 14A process, which was to ultimately replace the 18A process, up and running. Given some reports that suggested 18A would be used internally, as opposed to being used for foundry customers, the new revelation about Nova Lake may provide some support for that notion. Is Intel a Buy, Hold or Sell? Turning to Wall Street, analysts have a Hold consensus rating on INTC stock based on one Buy, 26 Holds and four Sells assigned in the past three months, as indicated by the graphic below. After a 33.49% loss in its share price over the past year, the average INTC price target of $21.60 per share implies 4.21% downside risk.
Business Insider
7 hours ago
- Business Insider
All Eyes on UnitedHealth Stock Ahead of Earnings — Here's What This Top Investor Expects
UnitedHealth Group (NYSE:UNH) stock just cannot seem to catch a break. The company's share price – already down in the dumps this year – suffered another setback earlier this month when health insurer Centene pulled its 2025 earnings guidance due to higher-than-expected costs among Medicaid beneficiaries. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. That move underscored a broader issue rippling through the healthcare sector: escalating costs. UnitedHealth itself is no stranger to this trend. As a quick reminder, it cited unexpectedly high medical expenses among Medicare Advantage beneficiaries as a key reason for withdrawing its full-year guidance back in May. Given the industry-wide pain, it's no surprise that investors are hoping the upcoming Q2 earnings report, due July 29, might offer some signs of relief. Unfortunately, that may be wishful thinking. One top investor, known by the pseudonym Quad 7 Capital, anticipates the earnings release could be 'rough.' Still, despite a host of negative signals, the investor also sees potential silver linings that shouldn't be overlooked. 'Headwinds galore from regulatory scrutiny, Medicare Advantage costs, and management changes, but insiders are buying, and the valuation is historically cheap,' explains Quad 7, who is among the top 2% of TipRanks' stock pros. Specifically, the investor suspects that Medicare Advantage costs likely remained a drag during the second quarter, particularly early on. But the key question is whether those costs have begun to stabilize – and how the company plans to manage them going forward. In addition, Quad 7 will be closely watching for any updates to guidance on the upcoming call, noting it's essentially a coin toss at this point. Any clarity on that front could significantly shape investor sentiment. Meanwhile, the relentless stream of bad news has driven UNH's valuation down to a level Quad 7 considers compelling. Despite the recent turmoil, the company continues to generate 'strong' free cash flows and maintain a solid return on equity – two signs that the core business remains fundamentally sound. 'Make no mistake, this is a profitable business even with all of the pain… We are looking for an inflection from this Q2 print,' Quad 7 concludes, assigning a Buy rating to UNH stock. (To watch Quad 7 Capital's track record, click here) Wall Street analysts largely agree. With 18 Buy ratings far outnumbering 7 Holds and just 1 Sell, UNH earns a Moderate Buy consensus rating. The average price target of $357.14 implies potential upside of ~22%. (See UNH stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
